Full article view2017-09-21T12:14:01+00:00
Back to News & Insights »

Precision Medicine Group Acquires Scientific and Medical Communications Company, ETHOS

EXPANDED EMPHASIS ON INTERPRETING THE SCIENCE OF COMPLEX MEDICAL INNOVATIONS
BOLSTERS PRECISION’S CAPABILITIES TO SUPPORT COMMERCIAL AND R&D CLIENT BASE

Bethesda, MD – Tuesday, July 10, 2018 – Precision Medicine Group, Inc., announced it is acquiring ETHOS Health Communications, a Pennsylvania-based agency specializing in the interpretation and communication of innovative medical science. The acquisition of ETHOS, which informs physicians, providers and other stakeholders through medical affairs- and marketing-based scientific content, allows Precision to offer its clients a significantly expanded cadre of doctoral-level science and medical communications specialists.

During its 15-year operating history, ETHOS has established itself as an authority in understanding and translating the science of medicine into high-level strategy and tactical execution. With a track record of long-tenured relationships with major biopharmaceutical companies and leading biotechnology firms, ETHOS has established a leadership position in the delivery of strategic scientific and medical communications and training solutions.

Commenting on the acquisition of ETHOS, Precision Medicine Group CEO Mark Clein explains, “As medical innovations become increasingly complex, the demand for clarity, insight and compelling communications becomes a fundamental success factor for drug developers seeking to convey the medical and economic benefits of their products. With ETHOS, these developers can better translate their science to the multiple constituents that prescribe, utilize, regulate and insure their products. With this addition, Precision has enhanced our proficiency in demonstrating the clinical value of medical innovations throughout the entire development and commercial life cycle.”

With more than 120 employees, including over 40 with doctoral degrees in science, ETHOS is headquartered in Yardley, PA, and is led by cofounder and president Anita O’Connor, who will join the leadership team of Precision Value & Health. O’Connor adds, “We are very happy to be joining the Precision family and partnering with other Precision teams to provide the highest level of expertise to help our clients achieve their objectives and to bring the best science and medicine to patients and healthcare professionals. Our company culture and mission align very closely with Precision’s, and we are very excited about the added value we can now offer both existing and new clients.”

Fairmount Partners, a leading investment bank worldwide for pharmaceutical, device and related service businesses, acted as exclusive financial advisor to ETHOS.

About ETHOS

Founded in 2002, ETHOS Health Communications provides scientific and medical marketing, medical affairs, and training solutions to pharmaceutical and biotech clients. Focused on interpreting and communicating the science of medicine, ETHOS is committed to delivering the best in science and strategy to create the highest-quality content and programming that informs, inspires and activates. For more information, visit ethoshc.com

About Precision Medicine Group

Formed in 2012, Precision Medicine Group is a specialized services company supporting next-generation approaches to drug development and commercialization. Precision provides an integrated infrastructure that supports pharmaceutical and life sciences companies as they develop new products in the age of precision medicine. The company is headquartered in Bethesda, MD, with offices throughout North America and Europe. For more information, visit precisionmedicinegrp.com

# # #

Media Contact:

Louis Landon
Precision Medicine Group Media Relations

310-984-7707

louis.landon@precisionmedicinegrp.com

Precision Medicine Group is an integrated team of experts in fields from advanced lab sciences to translational informatics and regulatory affairs, payer insights to marketing communications. Together, we help our pharmaceutical and life-sciences clients conquer product development and commercialization challenges in a rapidly evolving environment.

By continuing to use our website, you agree to our use of cookies to help us give you the best experience, analyze your site usage, and assist in our marketing efforts.
For more information, or to learn how to change your cookies preferences, please click here.

OK